Growth Metrics

Cardlytics (CDLX) Asset Writedowns and Impairment (2017 - 2025)

Cardlytics' Asset Writedowns and Impairment history spans 9 years, with the latest figure at $57.1 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $57.1 million; the TTM value through Dec 2025 reached $117.7 million, down 13.02%, while the annual FY2025 figure was $58.8 million, 55.28% down from the prior year.
  • Asset Writedowns and Impairment reached $57.1 million in Q4 2025 per CDLX's latest filing, down from $58.8 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $131.6 million in Q3 2024 to a low of -$246000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 5 years is $17.3 million, with a median of $1.0 million recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 171.1% in 2023, then skyrocketed 32074.82% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $262000.0 in 2021, then soared by 453.44% to $1.4 million in 2022, then surged by 4683.79% to $69.4 million in 2023, then skyrocketed by 89.71% to $131.6 million in 2024, then plummeted by 56.64% to $57.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Asset Writedowns and Impairment are $57.1 million (Q4 2025), $58.8 million (Q3 2025), and $1.2 million (Q2 2025).